After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
JNJ belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – General industry. The current market capitalization of Johnson & Johnson is $454.31B. A total of 8.66 million shares were traded on the day, compared to an average of 8.56M shares.
In the most recent transaction, Taubert Jennifer L sold 56,471 shares of JNJ for 177.81 per share on Sep 04 ’25. After the transaction, the EVP, WWC. Innovative Medicine now owns 178,013 company shares. In a previous transaction on Sep 04 ’25, Taubert Jennifer L bought 56,471 shares at 177.81 per share.
Among the insiders who bought shares, Forminard Elizabeth acquired of 9,570 shares on Aug 29 ’25 at a per-share price of $177.20. In another insider transaction, Duato Joaquin sold 125,824 shares at $179.21 per share on Aug 22 ’25. Company shares held by the CEO and Chairman of the Board now total 275,967.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Johnson & Johnson pays an annual dividend of $5.08, resulting in a dividend yield of 2.69%, and it has a price to earnings (P/E) ratio of 20.18.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, JNJ has a high of $186.59 and a low of $140.68.
As of this writing, JNJ has an earnings estimate of $2.75 per share for the current quarter. EPS was calculated based on a consensus of 18.0 estimates, with a high estimate of $2.9 per share and a lower estimate of $2.63. The company reported an EPS of $2.42 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. JNJ’s latest balance sheet shows that the firm has $31.61B in Cash & Short Term Investments as of fiscal 2021. There were $33.75B in debt and $45.23B in liabilities at the time. Its Book Value Per Share was $32.60, while its Total Shareholder’s Equity was $74.02B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JNJ is Buy with a score of 4.04.
